Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2006-06-27
2006-06-27
Tsang, Cecilia J. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S649000, C514S255030, C514S555000, C562S030000, C564S308000
Reexamination Certificate
active
07067555
ABSTRACT:
The present invention provides an essentially nonaqueous, liquid pharmaceutical concentrate composition for oral administration containing sertraline or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The present invention also provides a use of this concentrate composition to prepare an aqueous solution of sertraline. In addition, the present invention provides a method of using this concentrate composition to treat or prevent a variety of diseases or conditions. Finally, the present invention provides the compound, (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine methanesulfonate.
REFERENCES:
patent: 4962128 (1990-10-01), Doogan et al.
patent: 5597826 (1997-01-01), Howard et al.
patent: 0768083 (1997-04-01), None
Harper Nancy J.
Ranade Gautam R.
Welch Willard M.
Joran A. David
Oh Taylor Victor
Pfizer Inc
Tsang Cecilia J.
Zelson Steve T.
LandOfFree
Sertraline oral concentrate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sertraline oral concentrate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sertraline oral concentrate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3687843